Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab-Reference-Cited by-同舟云学术

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab

Published:2020-01-13 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Boyer-Suavet Sonia,Andreani Marine,Lateb Maël,Savenkoff Benjamin,Brglez Vesna,Benzaken Sylvia,Bernard Ghislaine,Nachman Patrick H.,Esnault Vincent,Seitz-Polski Barbara

Funder

Centre Hospitalier Universitaire de Nice

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy;Beck;N Engl J Med.,2009

2. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy;Tomas;N Engl J Med.,2014

3. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy;Beck;J Am Soc Nephrol.,2011

4. Prognosis of untreated patients with idiopathic membranous nephropathy;Schieppati;N Engl J Med.,1993

5. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy;Kanigicherla;Kidney Int.,2013

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines;European Journal of Pharmacology;2024-11

2. B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges;International Immunopharmacology;2024-10

3. Membranous Nephropathy: Updates on Management;Advances in Kidney Disease and Health;2024-07

4. A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis;Biomedicine & Pharmacotherapy;2024-06

5. Rituximab Resistance in Glomerular Diseases: A GlomCon Mini Review;Kidney Medicine;2024-04